| | Effective Health Care Clinician Guides
| | Making good decisions requires that physicians have reliable and practical data. Comparative effectiveness reviews and objective findings on different medical interventions and strategies, as provided by the Agency for Healthcare Research and Quality in its Effective Health Care Program, can help physicians make the most informed choices among treatment options. | |  |
|
|
| FDA approves drugs for HIV, HAE
| | | FDA has approved a combination formulation of emtricitabine/rilpivirine/tenofovir to treat HIV-1 infection in treatment-naive adults and icatibant to treat hereditary angioedema. |
| | Focus on 2011: A year of novel pharmacologic agents in review
| | | Throughout 2011, Formulary's "Focus on" articles have examined 10 newly approved or investigational drugs of interest to pharmacy and therapeutics (P&T) committee members. Because many readers have said they frequently refer to this column when making formulary decisions for hospitals, health systems, or managed care organizations, the editors have compiled this review of these agents, along with updates on the regulatory status of each. |
| | Effective Health Care Clinician Guides
| | | Making good decisions requires that physicians have reliable and practical data. Comparative effectiveness reviews and objective findings on different medical interventions and strategies, as provided by the Agency for Healthcare Research and Quality in its Effective Health Care Program, can help physicians make the most informed choices among treatment options. |
| | | Expert gives guidance on prophylaxis with laser, surgery procedures
| | | Although most dermatologists are aware of the latest studies on antibacterial and antiviral prophylaxis for surgical and laser procedures, many of them haven't changed their practices as a result, according to one expert. Dirk M. Elston, M.D., director, Ackerman Academy of Dermatopathology, New York, would like to convince them otherwise. |
|
| 
Practice Tools
